Access cutting-edge colitis treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access colitis specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colitis treatment provided free
The goal of this clinical trial is to compare the safety and effectiveness of infliximab compared to steroids for the treatment of immune checkpoint inhibitor-induced colitis (ICI colitis) in patients with stage III/IV skin cancer. The main questions this study aims to answer are: * How many patients treated with infliximab experience steroid-free disease resolution after 7 weeks? * How many patients treated with steroids experience steroid-free disease resolution after 7 weeks?
Sponsor: Massachusetts General Hospital
Check if you qualify for this colitis clinical trial in Boston, MA
If you're searching for colitis treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.